Alex Miras is currently a Senior Clinical Lecturer and Consultant in Endocrinology at Imperial College London and interested in the mechanisms through which lifestyle interventions, pharmacotherapy, bariatric surgery and medical devices improve weight, metabolic control and diabetes-related microvascular complications.
et al., 2022, Effect of obesity surgery on taste, Nutrients, Vol:14, ISSN:2072-6643, Pages:1-24
et al., 2022, Mechanisms of weight loss after obesity surgery, Endrocrine Reviews, Vol:43, ISSN:0163-769X, Pages:19-34
Miras AD, le Roux CW, 2022, Metabolicsurgery versus conventional therapy intype 2 diabetes (vol 397, pg 256, 2021), Lancet, Vol:399, ISSN:0140-6736, Pages:520-520
et al., 2022, Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysis, Diabetes, Obesity and Metabolism: a Journal of Pharmacology and Therapeutics, Vol:24, ISSN:1462-8902, Pages:337-342
et al., 2021, Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors, Therapeutic Advances in Endocrinology and Metabolism, Vol:12, ISSN:2042-0188, Pages:1-39